Ocular, otic, nasal, rectal and vaginal formulation innovations and regulatory considerations

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	217-217
Journal	Pharmaceutical Development and Technology
Volume	23
Issue number	3
Early online date	24 Jan 2018
DOIs	https://doi.org/10.1080/10837450.2018.1427530
Publication status	Published - 16 Mar 2018

Keywords

@article{4055924f640e4288a99c2a64968a149b,

title = "Ocular, otic, nasal, rectal and vaginal formulation innovations and regulatory considerations",

keywords = "Pharmacy, general medicine, pharmaceutical science",

author = "Raid Alany",

year = "2018",

month = mar,

day = "16",

doi = "10.1080/10837450.2018.1427530",

language = "English",

volume = "23",

pages = "217--217",

journal = "Pharmaceutical Development and Technology",

issn = "1083-7450",

publisher = "Taylor and Francis Ltd.",

number = "3",

}

TY - JOUR

T1 - Ocular, otic, nasal, rectal and vaginal formulation innovations and regulatory considerations

AU - Alany, Raid

PY - 2018/3/16

Y1 - 2018/3/16

KW - Pharmacy

KW - general medicine

KW - pharmaceutical science

U2 - 10.1080/10837450.2018.1427530

DO - 10.1080/10837450.2018.1427530

M3 - Article

SN - 1083-7450

VL - 23

SP - 217

EP - 217

JO - Pharmaceutical Development and Technology

JF - Pharmaceutical Development and Technology

IS - 3

ER -